the quality of the evidence was low. Strong concerns, however, were expressed among the Patient Panel about the potential for vaccines to cause a disease flare, and shared decision-making is particularly important in this setting. Most studies suggest that increased disease activity does not impact vaccine immunogenicity Managing immunosuppressive therapy at the time of live attenuated vaccination to avoid vaccine-associated illness (Table 5 For patients with RMD who are taking